Partnering Solutions
- 
                    Supporting Your Complex Immuno-Oncology Trials
                        3/4/2021
                    IQVIA Biotech offers extensive immuno-oncology (IO) expertise that spans across multiple treatment modalities (vaccines, bispecific antibodies, adoptive cell therapies [ACT], etc.) and numerous indications across hematologic malignancies and solid tumors. 
- 
                    Patient Recruitment And Site Selection
                        12/20/2022
                    Novotech relies on years of experience, in-country knowledge, and real-life big data to identify and propose the best-performing sites. Uncover the possibilities for your next study. 
- 
                    Solid Oral Dosage Contract Packaging
                    Ropack's ample available capacity brings efficiency to a wide range of options for the packaging of solid oral dosage. In nearly 250,000 sq. ft., Ropack operates 32 Clean Rooms in modular systems that allow for scalable growth and rapid expansion for packaging in blister, bottle, stick and sachet formats. 
- 
                    Transforming Clinical Trial Site Forecasting
                        10/30/2024
                    In today’s ever-evolving clinical trial space, managing the expenses associated with conducting a study is more important – and fraught – than ever before. 
- 
                    Forecast And Budget Investigator Grants Confidently
                        10/3/2024
                    Integrate data from all industry sources to confidently plan budgets for studies worldwide, across all phases and therapeutic areas. 
- 
                    Starting A New Study? This One's For You
                        10/15/2025
                    Choosing the right vendor at trial launch impacts costs, timelines, data integrity, and patient experience — yet vendor selection in clinical research remains fundamentally broken today. 
- 
                    Oncology Clinical Development
                        8/22/2024
                    Our extensive oncology expertise coupled with an end-to-end approach helps accelerate your clinical programs, giving you the confidence to bring breakthrough treatments to patients. 
- 
                    Unified Platform Solutions For Phase I Clinical Trials
                        3/19/2024
                    Phase I clinical trials need technological solutions that support rapid implementation and end-to-end processes. Signant’s unified eClinical platform provides the perfect partner for Phase I research. 
- 
                    An Introductory Guide To Clinical EU Qualified Person (QP) Services
                        10/3/2022
                    PCI's team of qualified persons assume responsibility for all stages of the process, safeguarding patients including the audit of the supply chain for GMP compliance in addition to certification of products for use in clinical trials. 
- 
                    GMP Auditing, Compliance, And Specialized Consulting
                        9/26/2023
                    Ready to make your research altogether better? Learn how Advarra® is assisting clients to reduce risk and ensure adherence to good manufacturing practice (GMP), good laboratory practice (GLP), and good tissue practice (GTP) standards. 
